3 trends to look out for at LogiPharma 2018

LogiPharma 2018 is just around the corner and TSS will be there. In case you can’t make it to Montreux, we’ve put together a trendspotting listicle to give you a brief outlook on what we expect to see at one of the world’s largest supply chain event.

1. Increased focus on Direct-to-Patient distribution

A patient driven supply chain is increasingly important in the life science industry. Visibility in Direct-to-Patient deliveries and secondary distribution creates opportunities in eliminating silos in the supply chain today. It also brings the pharma company closer to the patient, generating new ways of communicating with the patient, ensuring a happy customer and a strengthened brand.

Studies show that direct-to-patient distribution models are considered as a key competitive advantage in the life science supply chain. Still, only a few pharmaceutical companies have actually implemented this type of model. As patients are becoming increasingly connected and as they have greater expectations of the “care experience”, we are confident the industry will see much more of this patient centric approach. We are also certain that it’s going to be one of the hottest topics on the LogiPharma agenda this year.

2. Sustainability as a key driver

As the world’s focus shifts towards reducing carbon emissions, the life science industry faces a dilemma in adhering to strict safety standards while reducing its carbon footprint. It’s no longer just about removing regulatory headaches and achieving compliance – pharmaceutical companies need to make sure they minimize drug waste and over-production, and that they identify the most environmentally friendly ways of transporting drugs safely to patients. We can see that a growing number of pharmaceutical companies are establishing sustainability programs to ensure they reduce their environmental impact. This green thinking will definitely be a hot topic on the exhibition floor in Montreux.

3. Blockchain emerging as a major disruptor

Over the past few years, concepts such as big data, artificial intelligence (AI) and the Internet of Things (IoT) have been top of mind for almost everyone in the industry, and we’ve seen much reporting on these topics from all over the world. Even though new and emerging technologies are moving from concept to reality as we speak, there is still much more to explore.

One interesting area at the moment is how blockchain technology is emerging as a major disruptor for pharmaceutical supply chains. Thanks to the fact that information can’t be altered, we believe that together with IoT blockchain has the possibility to revolutionize the life science ecosystem. However, it’s important to have in mind that although the technology has high theoretical value, it’s still at a very early stage of development.

Currently studies are conducted to explore how blockchain-based distributed ledger technology can be used in the pharmaceutical supply chain, e.g. this one by The Center for Supply Chain Studies.

Come meet us in Montreux!

TSS is one of the sponsors of the LogiPharma event, taking place at the Montreux Music & Convention Centre April 10-12th. Come and meet with our cold chain experts onsite!

If you’d like to find out how our cloud solution can help you transform your supply chain, reach out to us and we’ll get in touch!

trends logipharma 2018

3 trends to look out for at LogiPharma 2018

trends logipharma 2018

LogiPharma 2018 is just around the corner and TSS will be there. In case you can’t make it to Montreux, we’ve put together a trendspotting listicle to give you a brief outlook on what we expect to see at one of the world’s largest supply chain event.

1. Increased focus on Direct-to-Patient distribution

A patient driven supply chain is increasingly important in the life science industry. Visibility in Direct-to-Patient deliveries and secondary distribution creates opportunities in eliminating silos in the supply chain today. It also brings the pharma company closer to the patient, generating new ways of communicating with the patient, ensuring a happy customer and a strengthened brand.

Studies show that direct-to-patient distribution models are considered as a key competitive advantage in the life science supply chain. Still, only a few pharmaceutical companies have actually implemented this type of model. As patients are becoming increasingly connected and as they have greater expectations of the “care experience”, we are confident the industry will see much more of this patient centric approach. We are also certain that it’s going to be one of the hottest topics on the LogiPharma agenda this year.

2. Sustainability as a key driver

As the world’s focus shifts towards reducing carbon emissions, the life science industry faces a dilemma in adhering to strict safety standards while reducing its carbon footprint. It’s no longer just about removing regulatory headaches and achieving compliance – pharmaceutical companies need to make sure they minimize drug waste and over-production, and that they identify the most environmentally friendly ways of transporting drugs safely to patients. We can see that a growing number of pharmaceutical companies are establishing sustainability programs to ensure they reduce their environmental impact. This green thinking will definitely be a hot topic on the exhibition floor in Montreux.

3. Blockchain emerging as a major disruptor

Over the past few years, concepts such as big data, artificial intelligence (AI) and the Internet of Things (IoT) have been top of mind for almost everyone in the industry, and we’ve seen much reporting on these topics from all over the world. Even though new and emerging technologies are moving from concept to reality as we speak, there is still much more to explore.

One interesting area at the moment is how blockchain technology is emerging as a major disruptor for pharmaceutical supply chains. Thanks to the fact that information can’t be altered, we believe that together with IoT blockchain has the possibility to revolutionize the life science ecosystem. However, it’s important to have in mind that although the technology has high theoretical value, it’s still at a very early stage of development.

Currently studies are conducted to explore how blockchain-based distributed ledger technology can be used in the pharmaceutical supply chain, e.g. this one by The Center for Supply Chain Studies.

Come meet us in Montreux!

TSS is one of the sponsors of the LogiPharma event, taking place at the Montreux Music & Convention Centre April 10-12th. Come and meet with our cold chain experts onsite!

If you’d like to find out how our cloud solution can help you transform your supply chain, reach out to us and we’ll get in touch!